Dhruvalben V. Shah's most recent trade in Remus Pharmaceuticals Ltd. was a Buy of 500 Equity Shares done at an average price of Rs. 721 . Disclosure was reported to the exchange on Dec. 15, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Dhruvalben V. Shah's has made SAST transactions in Remus Pharmaceuticals Ltd. recently where a Acquisition of 500 Equity shares done . Disclosure was reported to the exchange on Dec. 19, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Remus Pharma | Dhruvalben V. Shah | Promoter | Acquisition | 19 Dec 2025 | 500 | 700 | - | - | 11 Dec 2025 11 Dec 2025 |
SAST (Reg29(2)) | Equity shares | Open Market | |
| Remus Pharma | DHRUVALBEN V SHAH | Promoter Group | Buy | 15 Dec 2025 | 500 | 700 | - | 721 | 360,500 | 11 Dec 2025 11 Dec 2025 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Dhruvalben Vishal Shah | Other | Acquisition | 16 Dec 2025 | 150 | 550 (0%) | 0.00% | 761.5 | 114,225 | 11 Dec 2025 11 Dec 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Remus Pharma | DHRUVALBEN V SHAH | Promoter Group | Buy | 13 Aug 2025 | 200 | 200 (0%) | - | 854.7 | 170,945 | 07 Aug 2025 07 Aug 2025 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | DHRUVALBEN V SHAH | Promoter Group | Sell | 07 Jun 2024 | 375 | - (0%) | - | 7316.1 | 2,743,549 | 03 Jun 2024 03 Jun 2024 |
Insider Trading (-) | Equity Shares | Market Sale |